参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/27 | 1,052 | 1,061 | 1,045 | 1,054 | +3 | +0.3% | 1,861,700 |
2023/02/24 | 1,043 | 1,056 | 1,039 | 1,051 | +17 | +1.6% | 2,144,700 |
2023/02/22 | 1,047 | 1,050 | 1,026 | 1,034 | -8 | -0.8% | 1,868,800 |
2023/02/21 | 1,025 | 1,046 | 1,019 | 1,042 | +36 | +3.6% | 2,690,800 |
2023/02/20 | 1,003 | 1,007 | 999 | 1,006 | +11 | +1.1% | 845,600 |
2023/02/17 | 991 | 998 | 989 | 995 | -6 | -0.6% | 2,018,000 |
2023/02/16 | 999 | 1,001 | 993 | 1,001 | +2 | +0.2% | 1,741,300 |
2023/02/15 | 1,020 | 1,021 | 998 | 999 | -16 | -1.6% | 1,296,300 |
2023/02/14 | 1,015 | 1,019 | 1,010 | 1,015 | +7 | +0.7% | 1,486,700 |
2023/02/13 | 1,008 | 1,012 | 1,002 | 1,008 | +6 | +0.6% | 1,272,900 |
2023/02/10 | 994 | 1,003 | 987 | 1,002 | ±0 | ±0% | 1,410,300 |
2023/02/09 | 1,009 | 1,012 | 999 | 1,002 | -12 | -1.2% | 1,785,300 |
2023/02/08 | 987 | 1,015 | 983 | 1,014 | +23 | +2.3% | 2,604,800 |
2023/02/07 | 993 | 995 | 988 | 991 | ±0 | ±0% | 2,282,200 |
2023/02/06 | 995 | 998 | 987 | 991 | +4 | +0.4% | 2,077,900 |
2023/02/03 | 998 | 1,004 | 984 | 987 | -19 | -1.9% | 2,875,900 |
2023/02/02 | 1,007 | 1,012 | 1,003 | 1,006 | -1 | -0.1% | 1,999,700 |
2023/02/01 | 1,011 | 1,017 | 1,007 | 1,007 | -3 | -0.3% | 2,084,200 |
2023/01/31 | 1,014 | 1,019 | 1,005 | 1,010 | +5 | +0.5% | 1,991,900 |
2023/01/30 | 1,000 | 1,012 | 998 | 1,005 | -1 | -0.1% | 3,950,300 |
2023/01/27 | 1,008 | 1,024 | 1,005 | 1,006 | -2 | -0.2% | 3,233,400 |
2023/01/26 | 1,019 | 1,023 | 1,006 | 1,008 | -14 | -1.4% | 2,081,500 |
2023/01/25 | 1,019 | 1,025 | 1,008 | 1,022 | +3 | +0.3% | 1,967,100 |
2023/01/24 | 1,037 | 1,038 | 1,019 | 1,019 | -12 | -1.2% | 1,931,400 |
2023/01/23 | 1,030 | 1,032 | 1,022 | 1,031 | +5 | +0.5% | 1,216,400 |
2023/01/20 | 1,020 | 1,029 | 1,012 | 1,026 | +6 | +0.6% | 1,124,200 |
2023/01/19 | 1,024 | 1,030 | 1,018 | 1,020 | -4 | -0.4% | 812,800 |
2023/01/18 | 1,007 | 1,031 | 1,007 | 1,024 | +18 | +1.8% | 975,500 |
2023/01/17 | 1,000 | 1,009 | 997 | 1,006 | +1 | +0.1% | 1,033,400 |
2023/01/16 | 1,010 | 1,017 | 1,004 | 1,005 | -9 | -0.9% | 986,100 |
2023/01/13 | 1,026 | 1,038 | 1,010 | 1,014 | -23 | -2.2% | 1,443,200 |
2023/01/12 | 1,049 | 1,053 | 1,036 | 1,037 | -4 | -0.4% | 1,012,300 |
2023/01/11 | 1,028 | 1,047 | 1,027 | 1,041 | +24 | +2.4% | 1,993,900 |
2023/01/10 | 1,027 | 1,038 | 1,014 | 1,017 | -9 | -0.9% | 2,446,300 |
2023/01/06 | 1,038 | 1,042 | 1,020 | 1,026 | -4 | -0.4% | 2,009,900 |
2023/01/05 | 1,035 | 1,036 | 1,016 | 1,030 | -8 | -0.8% | 2,285,300 |
2023/01/04 | 1,064 | 1,064 | 1,037 | 1,038 | -36 | -3.4% | 1,692,200 |
2022/12/30 | 1,078 | 1,084 | 1,072 | 1,074 | -4 | -0.4% | 815,500 |
2022/12/29 | 1,088 | 1,091 | 1,073 | 1,078 | -8 | -0.7% | 785,700 |
2022/12/28 | 1,082 | 1,088 | 1,075 | 1,086 | +4 | +0.4% | 774,400 |
2022/12/27 | 1,091 | 1,095 | 1,082 | 1,082 | -8 | -0.7% | 737,100 |
2022/12/26 | 1,087 | 1,096 | 1,083 | 1,090 | +1 | +0.1% | 671,300 |
2022/12/23 | 1,084 | 1,095 | 1,083 | 1,089 | -4 | -0.4% | 1,070,800 |
2022/12/22 | 1,100 | 1,101 | 1,087 | 1,093 | -12 | -1.1% | 1,154,200 |
2022/12/21 | 1,098 | 1,114 | 1,093 | 1,105 | +7 | +0.6% | 1,739,400 |
2022/12/20 | 1,112 | 1,121 | 1,083 | 1,098 | -13 | -1.2% | 1,426,900 |
2022/12/19 | 1,114 | 1,119 | 1,106 | 1,111 | -7 | -0.6% | 1,496,300 |
2022/12/16 | 1,117 | 1,131 | 1,111 | 1,118 | -7 | -0.6% | 1,586,700 |
2022/12/15 | 1,137 | 1,140 | 1,125 | 1,125 | -15 | -1.3% | 1,034,900 |
2022/12/14 | 1,150 | 1,159 | 1,139 | 1,140 | -4 | -0.3% | 910,700 |
301~
350
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 156,900円 | -1.6% | +50.6% | 2.17% | 17.01倍 | 1.86倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 230,600円 | -10.5% | -24.9% | 3.47% | 11.90倍 | 1.37倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 288,100円 | +10.8% | +3.7% | 1.04% | 20.54倍 | 2.67倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 380,900円 | +7.3% | -3.8% | 2.36% | 18.26倍 | 1.09倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 395,700円 | +22.6% | +68.1% | 3.44% | 10.54倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム